Every one of those 1 sits in a single category, regulation. Anti-Corruption Branch is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 2 original sources on average. We currently track 1 Healthcare story that mention Central Procurement Agency, all published on August 18, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Central Procurement Agency
Every one of those 1 sits in a single category, regulation. Anti-Corruption Branch is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 2 original sources on average. We currently track 1 Healthcare story that mention Central Procurement Agency, all published on August 18, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 11 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Central Procurement Agency. Shared-story counts are live from our verified record — not editorial picks.
Healthcare stakeholders should track how alleged corruption in DGHS and the Central Procurement Agency inflated prices for medicines, surgical items and equipment, and what it means for patient access and public health budgets. The bail denial of Dr Vinod Kumar Ranga and the arrest of former DGHS Dr Vatsala Aggarwal put accountability pressure on health system leadership.